Načítá se...
Small molecule inhibitors of RAS proteins with oncogenic mutations
RAS proteins control a number of essential cellular processes as molecular switches in the human body. Presumably due to their important signalling role, RAS proteins are among the most frequently mutated oncogenes in human cancers. Hence, numerous efforts were done to develop appropriate therapies...
Uloženo v:
| Vydáno v: | Cancer Metastasis Rev |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer US
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7680341/ https://ncbi.nlm.nih.gov/pubmed/32770300 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10555-020-09911-9 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|